BELotaxel(Docetaxel) and bellOXa(Oxaliplatin) in Advanced NSCLC

NCT01243775 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Belotaxel
DRUG: Belloxa

Sponsor

Chonnam National University Hospital

Collaborators

[object Object]